首页> 外文期刊>Molecular Genetics and Metabolism Reports >First Japanese case of maternal phenylketonuria treated with sapropterin dihydrochloride and the normal growth and development of the child
【24h】

First Japanese case of maternal phenylketonuria treated with sapropterin dihydrochloride and the normal growth and development of the child

机译:日本首例使用盐酸沙丙蝶呤治疗的母亲苯丙酮尿症病例与儿童的正常生长发育

获取原文
           

摘要

Sapropterin dihydrochloride (SD) may be a new treatment option for women with phenylketonuria (PKU) who plan to become pregnant. We report the first Japanese case of maternal PKU treated with SD. The patient was administered SD at 10–20?mg/kg/day, which increased phenylalanine tolerance during the pregnancy and lactation. No adverse events occurred, and she delivered a healthy neonate. Normal growth and development of the child confirms the efficacy and safety of SD.
机译:盐酸沙丙蝶呤(SD)可能是计划怀孕的苯丙酮尿​​症(PKU)妇女的新治疗选择。我们报告了日本首例经SD治疗的孕妇PKU病例。每天给SD患者10-20?mg / kg /天,这在怀孕和哺乳期增加了苯丙氨酸的耐受性。没有发生不良事件,她分娩出健康的新生儿。儿童的正常生长发育证实了SD的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号